Ceesay Abraham Insider Trades

Insider Trading History

Track insider trading activity for Ceesay Abraham. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Charles River Laboratories International
Charles River Laboratories International CRL
Director
Holding Value $445k 2,384 shares
Last Trade
May 08, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$255k 1,438 shares
$177.62
$186.60
Rapport Therapeutics
Rapport Therapeutics RAPP
Chief Executive Officer
Holding Value $21.7M 558,528 shares
Last Trade
Feb 18, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$320k 10,916 shares
$29.35
$38.88
Rapport Therapeutics
Rapport Therapeutics RAPP
Chief Executive Officer
Holding Value $16.6M 428,000 shares
Last Trade
Feb 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.9M 428,000 shares
$27.75
$38.88
Rapport Therapeutics
Rapport Therapeutics RAPP
Chief Executive Officer
Holding Value $21.9M 562,080 shares
Last Trade
Jan 20, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$285k 10,916 shares
$26.12
$38.88
Rapport Therapeutics
Rapport Therapeutics RAPP
Chief Executive Officer
Holding Value $22.2M 571,305 shares
Last Trade
Dec 17, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$324k 10,916 shares
$29.64
$38.88
Rapport Therapeutics
Rapport Therapeutics RAPP
Chief Executive Officer
Holding Value $22.4M 576,802 shares
Last Trade
Nov 17, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$275k 10,916 shares
$25.20
$38.88
Rapport Therapeutics
Rapport Therapeutics RAPP
Chief Executive Officer
Holding Value $22.6M 580,765 shares
Last Trade
Oct 15, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$282k 10,916 shares
$25.81
$38.88
Rapport Therapeutics
Rapport Therapeutics RAPP
Chief Executive Officer
Holding Value $22.8M 586,812 shares
Last Trade
Sep 17, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.01M 76,420 shares
$26.32
$38.88
Pacira BioSciences
Pacira BioSciences PCRX
Director
Holding Value $213k 9,039 shares
Last Trade
Sep 04, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$64k 2,354 shares
$27.19
$23.51
Pacira BioSciences
Pacira BioSciences PCRX
Director
Holding Value $268k 11,393 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$275k 11,279 shares
$24.34
$23.51
Charles River Laboratories International
Charles River Laboratories International CRL
Director
Holding Value $389k 2,082 shares
Last Trade
Jun 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$409k 3,028 shares
$135.04
$186.60
Rapport Therapeutics
Rapport Therapeutics RAPP
Chief Executive Officer
Holding Value $16.6M 428,000 shares
Last Trade
Feb 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.1M 428,000 shares
$16.60
$38.88
Pacira BioSciences
Pacira BioSciences PCRX
Director
Holding Value $286k 12,179 shares
Last Trade
Jun 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$349k 12,179 shares
$28.68
$23.51
Pacira BioSciences
Pacira BioSciences PCRX
Director
Holding Value $728k 30,967 shares
Last Trade
Oct 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$923k 30,967 shares
$29.80
$23.51
Cerevel Therapeutics Holdings
Cerevel Therapeutics Holdings CERE
President
Holding Value $5.15M 114,445 shares
Last Trade
Feb 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.94M 114,445 shares
$34.41
$44.96
Cerevel Therapeutics Holdings
Cerevel Therapeutics Holdings CERE
President
Holding Value $0 0 shares
Last Trade
Sep 08, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$624k 19,210 shares
$32.50
$44.96
Cerevel Therapeutics Holdings
Cerevel Therapeutics Holdings CERE
President
Holding Value $864k 19,210 shares
Last Trade
Sep 08, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$618k 19,210 shares
$32.18
$44.96
Cerevel Therapeutics Holdings
Cerevel Therapeutics Holdings CERE
President
Holding Value $16.4M 365,009 shares
Last Trade
Sep 08, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$618k 19,210 shares
$32.18
$44.96
Cerevel Therapeutics Holdings
Cerevel Therapeutics Holdings CERE
President
Holding Value $0 0 shares
Last Trade
Aug 22, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$312k 9,605 shares
$32.50
$44.96
Cerevel Therapeutics Holdings
Cerevel Therapeutics Holdings CERE
President
Holding Value $17.3M 384,219 shares
Last Trade
Aug 22, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$313k 9,605 shares
$32.60
$44.96

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up